Ptosis (Drooping Eyelid / Brow)

In brief: Ptosis is a drooping of the eyelid or the eyebrow. In medical aesthetics it is most often seen as a temporary condition caused by botulinum toxin (Botox) spreading to muscles it was not intended to reach. It resolves on its own; apraclonidine drops may ease symptoms in eyelid ptosis. Prevention depends on the correct dose and technique in the hands of an experienced physician.

Definition: eyelid ptosis and brow ptosis

"Ptosis" means that a structure sits lower than its normal position. In facial aesthetics two different conditions are often confused:

• Eyelid ptosis (blepharoptosis): The upper eyelid itself droops. It is associated with the toxin reaching the levator palpebrae superioris, the muscle that raises the eyelid.
• Brow ptosis: It is the eyebrow, not the eyelid, that descends. It occurs when excessive weakening of the forehead muscle (frontalis) reduces the support that holds the brow up.

This distinction determines treatment; the two are not the same and are managed differently.

Why does Botox-related ptosis occur?

Botulinum toxin temporarily blocks nerve–muscle transmission in the muscle into which it is placed. When diffusion (spread) occurs from the target muscle to neighboring muscles, unwanted weakness develops. Contributing factors include a high dose/volume, deviation of the injection point from the target and anatomical variation. For this reason, the risk of eyelid/brow ptosis calls for particular care in glabellar (between the brows) and forehead treatments.

How is the clinical assessment carried out?

The assessment is not based only on how low the eyelid appears. The physician reviews the baseline photographs, the resting position of both eyebrows, the extent to which the forehead muscle is recruited to lift the brows and the upper eyelid crease together. Eyelid asymmetry present before treatment, excess skin known as dermatochalasis, or an unconscious tendency to keep using the forehead muscle to hold the brows up may become more noticeable after the procedure. This does not always mean that the toxin has spread to the muscle that raises the eyelid.

The timeline is important in the differential diagnosis. Drooping related to the effect of botulinum toxin is usually noticed in the days after treatment, as the effect of the drug becomes established. By contrast, if sudden drooping is accompanied by double vision, weakness in another part of the face, slurred speech, severe headache or a change in the pupil, it is not assumed to be a routine aesthetic side effect; urgent medical assessment is needed. An internet photograph or a remote message is not sufficient to rule out neurological or eye-related causes.

How long does it last?

The most important message: Botox-related ptosis is not permanent. Onset is typically noticed in the first days after the injection, and the condition regresses on its own as the effect of the toxin wears off over time. Its duration varies with the individual, the dose and the muscle affected; it should therefore be regarded as a "temporary and resolving" process rather than one with a fixed number of days.

Management

The approach varies with the condition and is planned only by the physician:

• Apraclonidine (0.5%) eye drops for eyelid ptosis: Through its alpha-adrenergic agonist effect it stimulates Müller's muscle and temporarily eases symptoms by raising the upper eyelid by a few millimeters. It is a prescription medicine; its use is the physician's decision.
• Watchful waiting and follow-up: Because the condition is temporary, monitoring under the physician's supervision is the mainstay in most cases.
• In brow ptosis the approach is different; an assessment that takes the forehead–brow balance into account is needed.

Apraclonidine is not a general solution for every type of ptosis. The drug's possible ocular and systemic side effects, the other medicines the person is taking and their eye health are assessed by the physician. Using drops prescribed for someone else, increasing the amount used or trying different eye drops together is not appropriate. The fact that the same benefit should not be expected in brow ptosis from a drop that targets an eyelid muscle shows why the distinction between eyelid and brow matters.

How are eyelid ptosis, brow ptosis and excess skin distinguished?

Key differences between types of drooping around the upper eye

Finding	Main structure	Clue in assessment
Eyelid ptosis	The muscle system that raises the upper eyelid	The eyelid margin moves closer to the pupil; brow position alone does not explain it
Brow ptosis	The muscle balance between the frontalis and the muscles around the brow	The brow descends and the upper eyelid may look heavier
Dermatochalasis	Upper eyelid skin and age-related excess tissue	The skin fold is more prominent than the eyelid margin; it may also be present before treatment

These conditions may also coexist. For example, in a person who originally compensated for excess upper eyelid skin by constantly raising the brows, excessive relaxation of the forehead muscle may cause the brow to drop and make the existing excess skin visible. For this reason, pre-treatment photographs, dynamic examination and the individual's own muscle balance matter as much as the assessment of the complication.

Prevention

The most effective "treatment" is prevention: an experienced physician with a thorough knowledge of anatomy, an appropriate dose and dilution, the correct injection point and depth, and patient-specific planning. Not rubbing the area in the first hours after treatment and following the instructions given by the physician also help to reduce the risk.

Prevention begins not with applying the same injection map to everyone but with recording brow shape, eyelid opening, forehead height, muscle strength and existing asymmetry. Previous eyelid surgery, marked upper eyelid heaviness or constant use of the frontalis to lift the brows may change the plan. Having experienced ptosis before does not automatically rule out a new treatment; the previous product, area, timing and recovery record are reviewed and the risk–benefit balance is re-established.

Monitoring and expected course

At follow-up, not only the aesthetic appearance is recorded but also whether the eyelid is affecting the field of vision, how the difference between the two sides is changing and any accompanying eye complaints. Photographs taken with the same lighting, angle and facial expression can help in understanding the course; even so, a photograph does not replace an examination. As the effect of botulinum toxin wears off, the condition usually regresses gradually. The follow-up interval is set by the physician according to the time of onset, the degree of the finding and the person's daily functioning.

Attempting to restore balance with a new injection is not the right option in every case. The aim of any additional treatment, its possible contribution and the risk of creating a new asymmetry are assessed separately. The safe approach is for the patient not to plan self-massage, prescription drops or additional botulinum toxin on their own, and to have the change assessed by the physician who performed the treatment and, where necessary, by an ophthalmologist or neurologist.

When should you see a physician?

When drooping of the eyelid/brow is noticed, you should contact the physician who performed the treatment. A change in vision, severe or disproportionate pain, or unexpected findings always require prompt assessment.